Dr. Moopen’s Family increases 4% stake for Rs. 460 crore in Aster DM Healthcare
The increase of stake in Aster DM Healthcare is a reiteration of the confidence in the business across geographies
The increase of stake in Aster DM Healthcare is a reiteration of the confidence in the business across geographies
The award recognizes and supports promising female scientists working in mass spectrometry
This initiative encapsulates the essence of OPPI’s commitment towards enabling a healthier India
ELL will be the preferred source of supply for some the key Raw Materials to VPPL at "Arm's Length" transaction.
This loan is in addition to earlier announced CAD 25 million loan committed by the Province of Quebec
New Building at Rockford, Illinois site will significantly increase equipment and capacity for injectable biologics and other self-administered therapies
A funding to expand operations and provide better patient care
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
The Development Center with its state-of-the art laboratories and flexible pilot capacities is set to become Siegfried's global research and development hub for its Drug Products sites, strengthening the global network
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
Subscribe To Our Newsletter & Stay Updated